Validation of a Clinical Prediction Rule to Identify Patients With Shoulder Pain Likely to Benefit From Cervicothoracic Manipulation: A Randomized Clinical Trial

NCT01571674 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2016-05-17

No results posted yet for this study

Summary

The purpose of this study is to determine the validity of previously identified prognostic variables that may identify patients with shoulder pain that are likely to benefit from cervicothoracic spine manipulation.

Conditions

  • Shoulder Pain

Interventions

PROCEDURE

Manipulation + Exercise Group

First 2 sessions * High-velocity, low-amplitude manipulations to the thoracic spine. * Low-velocity mid to end-range mobilizations to the cervical spine. * Active Range of Motion Exercises for the cervicothoracic spine Final 6 sessions ◦ Evidence based shoulder girdle exercise program

PROCEDURE

Exercise Group

First 2 sessions ◦ Active Range of Motion Exercises for the cervicothoracic spine Final 6 sessions ◦ Evidence based shoulder girdle exercise program

Sponsors & Collaborators

  • Virginia Commonwealth University

    collaborator OTHER
  • University of Colorado, Boulder

    collaborator OTHER
  • Northern Navajo Medical Center

    collaborator UNKNOWN
  • Gundersen Lutheran Health System

    collaborator OTHER
  • Waldron's Peak Physical Therapy

    collaborator UNKNOWN
  • Temple University

    collaborator OTHER
  • University of Colorado, Denver

    lead OTHER

Principal Investigators

  • Paul Mintken, DPT · University of Colorado, Denver

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2014-12-31
Completion
2015-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01571674 on ClinicalTrials.gov